Definitive Healthcare Q2 revenue $61M (+12% YoY), acquires Populi; guides Q3 rev $63-64.5M

Definitive Healthcare Corp.

2023-Q2 EPS reported -$0.19 revenue$120,158,000

Revenue $61.0M (+12% YoY); net loss widened to $11.6M from $10.1M; adjusted EBITDA $17.2M (28% of revenue).
Acquired Populi, a provider-focused data and analytics company; strengthens Atlas Dataset with new data and analytic tools for provider market.
Restated prior financials due to sales tax misstatements; aggregate G&A increase of $8.5M through March 2023.
Q3 2023 guidance: revenue $63-64.5M, adjusted EBITDA $17.5-18.5M, adjusted EPS $0.05-0.07.
Full-year 2023 guidance: revenue $249-255M, adjusted EBITDA $67-71M, adjusted EPS $0.19-0.23; expects revenue in lower half, profitability in upper half.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

Definitive Healthcare Corp. reported the quarter ended June 30, 2023 results: revenue $61.0 million, net income ($11.6) million.

Period: the quarter ended June 30, 2023
Revenue: $61.0 million
Net income: ($11.6) million
Result: reported results

Exact text from the filing

Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2023 Second quarter revenue grew 12% year-over-year to $61.0 million

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Definitive Healthcare Corp. filing history →

Source: SEC EDGAR

accession 0000950170-23-042417

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.